tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
uniQure N.V. (QURE)
NASDAQ:QURE
US Market
QURE
uniQure
RESEARCH TOOLSreports
Advertisement

uniQure (QURE) Stock News & Sentiment

Compare
1,261 Followers
UniQure (QURE) Stock Jumps 248% on Huntington’s Trial Results. Analysts Raise Price Targets
Premium
Market News
UniQure (QURE) Stock Jumps 248% on Huntington’s Trial Results. Analysts Raise Price Targets
1d ago
CLPT
HTGC
uniQure Announces Positive Results for Huntington’s Study
Premium
Company Announcements
uniQure Announces Positive Results for Huntington’s Study
1d ago
8K
QURE
uniQure Secures $175 Million Loan Amendment
Premium
Company Announcements
uniQure Secures $175 Million Loan Amendment
1d ago
8K
QURE
uniQure’s Promising Advancements in Huntington’s Disease Treatment and Strong Financial Position Justify Buy Rating
Premium
Ratings
uniQure’s Promising Advancements in Huntington’s Disease Treatment and Strong Financial Position Justify Buy Rating
2d ago
QURE
uniQure’s AMT-130 Gene Therapy Shows Promising Results in Huntington’s Disease Trials, Justifying Buy Rating and $70 Price Target
Premium
Ratings
uniQure’s AMT-130 Gene Therapy Shows Promising Results in Huntington’s Disease Trials, Justifying Buy Rating and $70 Price Target
2d ago
QURE
Buy Rating for uniQure Driven by Promising Gene Therapy Data and Future Growth Potential
Premium
Ratings
Buy Rating for uniQure Driven by Promising Gene Therapy Data and Future Growth Potential
21d ago
QURE
Buy Rating for uniQure: Promising Developments in Huntington’s Disease Treatment AMT-130
Premium
Ratings
Buy Rating for uniQure: Promising Developments in Huntington’s Disease Treatment AMT-130
24d ago
QURE
More QURE News >

QURE News on the Web

Stocks making the biggest moves midday: Mirion Technologies, Freeport-McMoRan, CarMax & more
CNBC
Neutral
QURE Stock Skyrockets on Meeting Goals in Huntington's Disease Study
Zacks
Neutral
Stocks making the biggest premarket moves: Intel, Oracle, Lithium Americas, Opendoor and more
CNBC
Neutral
uniQure's $200 Million Public Offering Proposal Signals Strategic Push in Gene Therapy Expansion
Market Chameleon
Neutral
Strength Seen in uniQure (QURE): Can Its 247.7% Jump Turn into More Strength?
Zacks
Neutral
Mizuho Securities Reaffirms Their Buy Rating on uniQure (QURE)
TipRanks News
Neutral
Why uniQure N.V.’s (QURE) Stock Is Up 5.64%
AAII
Neutral
Top Stocks today: uniQure, Lithium Americas and Tesla soar
TheStreet.com
Neutral

News Score - Last 7 Days

Neutral
QURE
Sector Average
Media Buzz
This Week20 articles
Weekly Average5.5 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is QURE’s Media Buzz Sentiment?
20 articles about QURE were published this week. In an average week, 5.5 articles are published.
    What is QURE’s weekly average amount of articles?
    In an average week, 5.5 articles about QURE are published.
      What is QURE’s News Sentiment?
      50% of articles about QURE were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        COLLCollegium Pharmaceutical
        MBXMBX Biosciences, Inc.
        ACADACADIA Pharmaceuticals
        CDTXCidara Therapeutics
        SAVACassava Sciences
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing